BoA Lowers Quest Diagnostics to 'Buy'

Analyst Todd Richter says Lab Corp.'s earnings shortfall anouncement has created uncertainty and confusion in the medical testing sector

Banc of America downgraded Quest Diagnostics (DGX ) to buy from strong buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.